Alfresa Holdings Corporation (TYO:2784)
Japan
· Delayed Price · Currency is JPY 1,926.50
-42.50 (-2.16%)
May 20, 2025, 3:30 PM JST
Alfresa Holdings Revenue
In the fiscal year ending March 31, 2025, Alfresa Holdings had annual revenue of 2.96T JPY with 3.59% growth. Alfresa Holdings had revenue of 698.73B in the quarter ending March 31, 2025, with 2.95% growth.
Revenue
2,961.05B
Revenue Growth
+3.59%
P/S Ratio
0.12
Revenue / Employee
236.56M
Employees
12,517
Market Cap
350.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 2,961.05B | 102.55B | 3.59% |
| Mar 31, 2024 | 2,858.50B | 162.43B | 6.02% |
| Mar 31, 2023 | 2,696.07B | 110.43B | 4.27% |
| Mar 31, 2022 | 2,585.64B | -17.53B | -0.67% |
| Mar 31, 2021 | 2,603.17B | -95.34B | -3.53% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Daiichi Sankyo Company | 1,886.26B |
| Takeda Pharmaceutical Company | 4,581.55B |
| HOYA Corporation | 869.37B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 997.33B |